Lisata Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $100 | $0 | $70 | $0 |
Gross Profit | 85 | 70 | -43 | |
EBITDA | -3,064 | -4,205 | -4,615 | -5,804 |
EBIT | -3,079 | -4,249 | -4,659 | -5,847 |
Net Income | -2,954 | -4,249 | -4,659 | -4,724 |
Net Change In Cash | 100 | 0 | 70 | 0 |
Free Cash Flow | -3,249 | -3,342 | -3,984 | -5,430 |
Cash | 15,956 | 18,998 | 16,835 | 20,217 |
Basic Shares | 8,687 | 8,738 | 8,605 | 8,602 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $170 | $1,000 | $0 | $121,372 |
Gross Profit | 24 | 1,000 | -189 | 63,771 |
EBITDA | -18,063 | -22,235 | -25,519 | -57,532 |
EBIT | -18,209 | -22,409 | -25,708 | -57,601 |
Net Income | -16,586 | -19,985 | -20,840 | -54,225 |
Net Change In Cash | 170 | 1,000 | 0 | 121,372 |
Free Cash Flow | -15,977 | -19,356 | -20,032 | -21,455 |
Cash | 15,956 | 16,209 | 22,593 | 32,154 |
Basic Shares | 8,687 | 8,329 | 8,073 | 5,180 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.33 |
2025-09-30 | -$0.49 |
2025-06-30 | -$0.54 |
